Phase 4 N=23 Study of the Safety and Efficacy of Botox in Bruxism
Bruxism
Primary: Bruxism Questionnaire Baseline and at Week 4 — 19.4; 16.1; 24.0; 24.0 units on a scale — p=0.0394
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=21 Occlusal Adjustment as Treatment for Chronic Orofacial Pain
Temporomandibular Joint Disorders · Orofacial Pain
Primary: Visual Analogic Scale for Pain Intensity (0-10) — 6.52; 4.8; .81; 2.05 units on a scale
N/A N=67 Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV
Sleep Bruxism · Tooth Wear
Primary: Total Number of Nights of Splint Wear for Four Months Per Subject. — 93.6; 98.7 nights — p=0.23
N/A N=72 Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
Bruxism · Sleep Bruxism, Adult · Awake Bruxism
Primary: Pain Intensity Measured by Visual Analog Scale (VAS) — 8.909; 8.957; 9.167; 1.591 VAS score (0-10)
Phase 3 N=58 Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders
Temporomandibular Disorders
Primary: Pain Intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)) — 5.40; 5.53; 3.90; 3.89 units on a scale
N/A N=80 Conservative Treatment of Patients With Temporomandibular Disorders
Temporomandibular Disorders
Primary: Patient-Rated TMD Pain, an 11 Point Numerical Rating Scale (NRS) — 0.9; 1.4; 1.6; 0.7 units on a scale
N/A N=14 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis
Peripheral Nerve Facial Nerve Paralysis · Facial Nerve Diseases · Orofacial Pain
Primary: The Visual Analog Scale for Pain Was Used to Grade Discomfort in Chewing After the Installation of Facial Paralysis. Level Zero is the Lack of Discomfort and 10 is the…
N/A N=171 Assessing a New Jaw Support Device During Third Molar Extractions
Impacted Third Molar Tooth · Temporomandibular Disorder
Primary: Occurrence of Pain at Follow-up With Wide Opening, or Pain in the Temple, Jaw Joint or Jaw Muscles. — 26; 32; 54; 53 Participants
N/A N=20 Dental Appliance for Parkinson's Disease
Parkinson Disease
Primary: Changes in Gait Velocity — 1.10; 1.15 m/s
N/A N=24 Motor Cortex as a Research & Therapeutic Target in TMD
Temporomandibular Joint Disorders
Primary: Number of Participants With Pain Relief as Measured by Visual Analog Scale (VAS) Decrease of 50% or Greater From Baseline — 4; 9 participants
N/A N=80 Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology
Temporomandibular Joint Dysfunction Syndrome
Primary: Assessing Graded Chronic Pain Severity Evaluation Feasibility of the PACT Program — -12; -19 units on a scale
Phase 3 N=604 OTC Mouthpiece for Snoring
Snoring
Primary: Snoring Severity Scale — -4.1 units on a scale — p=< 0.0001
N/A N=600 Timing of Dietary Acid Intake, Brushing Teeth and Acid Erosion.
Tooth Wear
Primary: Basic Erosive Wear Examination — 15.01; 6.27 Units on a scale — p=<0.05